Critique of the 2017 epileptic seizure and epilepsy classifications.


Journal

Epilepsia
ISSN: 1528-1167
Titre abrégé: Epilepsia
Pays: United States
ID NLM: 2983306R

Informations de publication

Date de publication:
06 2019
Historique:
received: 25 05 2018
revised: 15 08 2018
accepted: 04 03 2019
pubmed: 30 3 2019
medline: 11 4 2020
entrez: 30 3 2019
Statut: ppublish

Résumé

This article critiques the International League Against Epilepsy (ILAE) 2015-2017 classifications of epilepsy, epileptic seizures, and status epilepticus. It points out the following shortcomings of the ILAE classifications: (1) they mix semiological terms with epileptogenic zone terminology; (2) simple and widely accepted terminology has been replaced by complex terminology containing less information; (3) seizure evolution cannot be described in any detail; (4) in the four-level epilepsy classification, level two (epilepsy category) overlaps almost 100% with diagnostic level one (seizure type); and (5) the design of different classifications with distinct frameworks for newborns, adults, and patients in status epilepticus is confusing. The authors stress the importance of validating the new ILAE classifications and feel that the decision of Epilepsia to accept only manuscripts that use the ILAE classifications is premature and regrettable.

Identifiants

pubmed: 30924146
doi: 10.1111/epi.14699
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1032-1039

Commentaires et corrections

Type : CommentIn

Informations de copyright

Wiley Periodicals, Inc. © 2019 International League Against Epilepsy.

Auteurs

Hans Lüders (H)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Naoki Akamatsu (N)

Department of Neurology, International University of Health and Welfare School of Medicine, Narita, Japan.

Shahram Amina (S)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Christoph Baumgartner (C)

Department of Neurology, Rosenhügel Neurological Center, Hietzing General Hospital, Vienna, Austria.
Karl Landsteiner Institute for Clinical Epilepsy Research and Cognitive Neurology, Medical Faculty, Sigmund Freud University, Vienna, Austria.

Selim Benbadis (S)

Departments of Neurology and Neurosurgery, University of South Florida, Tampa, Florida.

Adriana Bermeo-Ovalle (A)

Department of Neurological Sciences, Rush University Medical Center, Chicago, Illinois.

Andrew Bleasel (A)

Department of Neurology, Westmead Hospital, University of Sydney, Westmead, New South Wales, Australia.

Alireza Bozorgi (A)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Mar Carreño (M)

Epilepsy Unit, Clinical Hospital, Barcelona, Spain.

Michael Devereaux (M)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Guadalupe Fernandez-Baca Vaca (G)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Stefano Francione (S)

Claudio Munari Epilepsy Surgery Center, Niguarda Hospital, Milan, Italy.

Naiara García Losarcos (N)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Hajo Hamer (H)

Department of Neurology, University of Erlangen, Erlangen, Germany.

Hans Holthausen (H)

Neuropediatric Clinic and Clinic for Neurorehabilitation, Epilepsy Center for Children and Adolescents, Schoen Clinic, Vogtareuth, Germany.

Shirin Jamal Omidi (S)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Giridhar Kalamangalam (G)

Department of Neurology, University of Florida, Gainesville, Florida.

Andrés Kanner (A)

Comprehensive Epilepsy Center, Miller School of Medicine, University of Miami, Miami, Florida.

Susanne Knake (S)

Department of Neurology, Marburg University Hospital, Marburg, Germany.

Nuria Lacuey (N)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Samden Lhatoo (S)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Shih-Hui Lim (SH)

Department of Neurology, National Neuroscience Institute, Singapore City, Singapore.

Jayanthi Mani (J)

Kokilaben Dhirubhai Ambani Hospital and Research Center, Mumbai, India.

Riki Matsumoto (R)

Department of Neurology, Kyoto University Hospital, Kyoto, Japan.

Jonathan Miller (J)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Soheyl Noachtar (S)

Department of Neurology, University of Munich Hospital, Ludwig Maximilian University, Munich, Germany.

André Palmini (A)

Neurology Service and Epilepsy Surgery Program, School of Medicine, Pontifical Catholic University of Rio Grande do Sul, Porto Alegre, Brazil.

Jun Park (J)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Felix Rosenow (F)

Neurology and Neurosurgery Center, Frankfurt University Hospital, Goethe University, Frankfurt am Main, Germany.

Asim Shahid (A)

Department of Neurology, University Hospitals Cleveland Medical Center, Cleveland, Ohio.

Stephan Schuele (S)

Feinberg School of Medicine, Northwestern University, Chicago, Illinois.

Bernhard Steinhoff (B)

Kork Epilepsy Center, Kehl-Kork, Germany.

Charles Ákos Szabo (CÁ)

Department of Neurology, Health Science Center, University of Texas, San Antonio, Texas.

Nitin Tandon (N)

Department of Neurosurgery, Memorial Hermann Texas Medical Center, Houston, Texas.

Kiyohito Terada (K)

Shizuoka Institute of Epilepsy and Neurological Disorders, Shizuoka, Japan.

Walter Van Emde Boas (W)

Department of Clinical Neurophysiology, Epilepsy Institutions Netherlands Foundation, Hoofddorp, The Netherlands.

Peter Widdess-Walsh (P)

National Centre for Epilepsy Surgery, Beaumont Hospital, Dublin, Ireland.

Philippe Kahane (P)

Neurology Department and Grenoble Institute of Neurosciences, National Institute of Health and Medical Research U-1216, Grenoble Alpes University Hospital, Grenoble, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH